OP0315. In ERA CATCH cohort fatigue final improvement lags behin remission by approx 6 months. So tell pts with RA that maximal improvement in fatigue lags a bit. #EULAR2019 @RheumNow

New #EULAR2019 data finds a link between vitamin D deficiency and disease activity among #spondyloarthritis patients. This could help explain the cause of "osteoporosis related to spondyloarthritis, and may adversely affect the patient’s functional status and quality of life."

There is no clear relationship between ANCA titer and vasculitis relapse, but patients with negative ANCA seem to have less relapses. #EULAR2019 #vasculitis

Congratulations to @Yuz6Yusof, awarded best #EULAR2019 abstract! His work 👉🏼recommended monitoring immunoglobulins baseline & b4 rituximab cycles to identify patients at risk of severe infections https://t.co/bOdwVLlXnL

Interesting discussion about nocebo effect when swapping to biosimilars. “Cheaper” may trigger this. Health professionals need to understand we are salespeople in many situations. Language, trust, style matter. #EULAR2019 https://t.co/29GP6cmXhQ

Optimal bimekizumab dose in PsA still remains to be determined.

Ritchlin: Bimekizumab (anti-IL17A & F) Phase 2B in active PsA = rapid response but also further increases wk12 to wk20 and sustained to wk48. #eular2019 @RheumNow https://t.co/yblCNmTxR4

@_connectedcare @RheumNow Certainly good rationale for also blocking IL-17F from pathophysiology point of view but will need to see if leads to diffs in RCTs…may also be important for IBD/other conditions

@StefanSiebert1 @RheumNow Do you think (gut feel) the combined inhibition of A & F looks better than IL17A inhibition alone? I know hard to compare without H2H but given you’re in this field of research...#eular2019

RELIEF clinical trial to evaluate efficacy a treatment for #Behçet's Syndrome.. #Apremilast 30 BID demonstrated efficacy at week 12 decreases activity in number and pain of oral ulcers.. - Gulen Hatemi #EULAR2019 https://t.co/iQHErUBIeO

GIACTA follow-up #eular2019 RT @drdavidliew: Flares: well, I had hoped for more from that top highlighted line. What is going to happen to our real-life patients who have had a year of TCZ and then come off? https://t.co/iGQN5HjADd

Motivating presentation on how to bring the future to the present, by Prof. McInnes. Identifying clusters of patients with PsA using Machine Learning. First step to achieve a personalized treatment for every patient #EULAR2019 https://t.co/5xRECw0gG5

In a large Danish study of #RA patients, those on #biologics and those on conventional #DMARDs had the same incidence of #jointreplacement #EULAR2019 https://t.co/ZgdkVZ8sYa

Ross Wilkie and his team found walking frequency, depression and insomnia are #mediators of #osteoarthritis effects on #mortality. https://t.co/sXhff6moFd

• Dr James Prior on Twitter: "Congratulations to Ross Wilkie from @PCScience…

What happens to the #muscles in patients with Giant Cell Arteritis after prolonged #steroid treatment?🤔 Find out at #EULAR2019 poster THU0605 Dr Alfuraih will explain using #ultrasound #shearwave #elastography #muscle #imaging https://t.co/VrzfdNiE3I